1stOncology™: Cancer Intelligence Service – Page 15128 – 1stOncology is recognized as a Top 10 Global Pharma Analytic Provider

Eleven Biotherapeutics to Present at Biotech Showcase 2018

On January 2, 2018 Eleven Biotherapeutics, Inc. (NASDAQ:EBIO), a late-stage clinical oncology company advancing novel product candidates based on its Targeted Protein Therapeutics (TPTs) platform, reported that Stephen Hurly, President and Chief Executive Officer, will present a company overview at the 2018 Biotech Showcase in San Francisco, CA on Tuesday, January 9, 2018 at 11:00 a.m. PST (Press release, Eleven Biotherapeutics, JAN 2, 2018, View Source [SID1234522817]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

Schedule Your 30 min Free Demo!

A live webcast can be accessed from the Investors & Media section of Eleven’s website, www.elevenbio.com. An archived replay of the webcast will be available on the Company’s website for 90 days after the conference.

Jazz Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference on January 8

On January 2, 2018 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) reported that the company will be webcasting its corporate presentation at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco, CA (Press release, Jazz Pharmaceuticals, JAN 2, 2018, View Source;p=RssLanding&cat=news&id=2324485 [SID1234522819]).

Bruce Cozadd, chairman and chief executive officer, will provide an overview of the company and a business and financial update at the conference on Monday, January 8, 2018 at 9:30 a.m. PST / 5:30 p.m. GMT.

A live audio webcast of the presentation may be accessed from the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com. Please connect to the website prior to the start of the presentation to ensure adequate time for any software downloads that may be necessary to listen to the webcast.

An archive of the webcast will be available for at least one week following the presentation on the Investors section of the company’s website at www.jazzpharmaceuticals.com.

Neurocrine Biosciences to Present at the 36th Annual J.P. Morgan Healthcare Conference

On January 2, 2018 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) reported that it will present at the 36th Annual J.P. Morgan Healthcare Conference at 3:00 p.m. PT (6:00 p.m. ET) on Monday, Jan. 8, 2018, in San Francisco (Press release, Neurocrine Biosciences, JAN 2, 2018, View Source;p=RssLanding&cat=news&id=2324471 [SID1234522820]). Kevin Gorman, CEO of Neurocrine Biosciences, will present at the conference.

The live presentation will be webcast and may be accessed on the Company’s website at View Source A replay of the presentation will be available on the website approximately one hour after the conclusion of the event and will be archived for one month

pSivida to Present at the Annual Biotech Showcase Conference

On January 2, 2018 pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release drug delivery products, reported that Nancy Lurker, President and Chief Executive Officer, will present at the Annual Biotech Showcase conference on Monday, January 8, 2018 at 3:00 p.m. PT in San Francisco, CA (Press release, pSivida, JAN 2, 2018, View Source [SID1234522821]).

A live audio and/or webcast and subsequent archived replay of pSivida’s presentations may be accessed via the Investors section of the Company’s website under "Resources – Events & Presentations" at www.psivida.com. The replay will be available for 90 days after the event.

Supernus to Present at the 2018 J.P. Morgan Healthcare Conference

On January 2, 2018 Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, reported that the Company’s management will present an overview and update for the Company, and host investor meetings at the 36th Annual J.P. Morgan Healthcare Conference (Press release, Supernus, JAN 2, 2018, View Source [SID1234522822]).

Date: Wednesday, January 10, 2018
Time: 12:00 p.m. PT / 3:00 p.m. ET
Place: Westin St. Francis Hotel, San Francisco, CA

Investors interested in arranging a meeting with the Company’s management during these conferences should contact the conference coordinator.

A live webcast of the presentation can be accessed by visiting ‘Events & Presentations’ in the Investors Section on the Company’s website at www.supernus.com. An archived replay of this webcast will be available for 60 days subsequent to the Company’s presentation.